# HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
> **ANDA207176** · Abbreviated New Drug Application (Generic) · Sponsor: AVANTHI INC · Approved 2017-08-07
## Drug
- **FDA Application Number:** ANDA207176
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
- **Generic name:** HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
- **Active ingredients:** HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AVANTHI INC
- **Manufacturer:** KVK-Tech, Inc.
- **First approval:** 2017-08-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207176)
---
*MORVS · CC0 1.0*